KIT and acute myeloid leukemia: Gao et al., instead, demonstrated a synergistic apoptotic effect of 5-azacytidine and miR-193a mimic combination in AML cell line, Kasumi-1, suggesting miR-193a restoration as a potential adjuvant therapy in c-KIT-positive AML [100].